Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,121 across all filing types
Latest filing 2012-10-03 Capital/Financing Update
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
SECTION 708AA NOTICE 2 pages 23.6KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708AA(2)(f) of the Corporations Act 2001 related to an entitlement offer by Mayne Pharma Group Limited. It discusses compliance with disclosure requirements and the effect of the entitlement offer on control of the company. The document is short (2523 characters) and serves as a formal announcement regarding a capital raising event without detailed financial statements or analysis. It is not a full financial report, earnings release, or management discussion. The content fits the category of a Capital/Financing Update, as it provides information about a fundraising activity (entitlement offer) and related regulatory compliance.
2012-10-03 English
Media Speculation 1 page 97.6KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement from Mayne Pharma addressing media speculation about a potential capital raising. It states that the company is reviewing strategic options including a possible capital raising, but no decision has been made yet. The document is brief (1065 characters) and does not contain any financial data or detailed report content. It is clearly an update on potential financing activity, but since it is preliminary and no actual capital raising has been undertaken or finalized, it fits best as a Capital/Financing Update (CAP).
2012-09-23 English
Media Speculation 1 page 97.6KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement from Mayne Pharma addressing media speculation about a potential capital raising. It states that the company is reviewing strategic options including a possible capital raising, but no decision has been made yet. The document is brief (1065 characters) and does not contain any financial data or detailed report content. It is clearly an update on potential financing activity, but since it is preliminary and no actual capital raising has been undertaken or finalized, it fits best as a Capital/Financing Update (CAP).
2012-09-23 English
Annual Report to shareholders 78 pages 2.1MB
Annual Report Classification · 100% confidence The document is titled 'annual REpoRt 2012' and repeatedly references 'Mayne Pharma Annual Report 2012'. It contains detailed sections typical of an annual report, including a Chairman's letter, Chief Executive Officer's review, financial summary, Directors' Report, Remuneration Report, auditor's independence declaration, corporate governance statement, consolidated financial statements, notes to the financial statements, Directors' Declaration, and independent auditor's report. The length is substantial (15,000 characters), and the content includes comprehensive financial data and management discussion. This matches the definition of an Annual Report (10-K). FY 2012
2012-09-20 English
Becoming a substantial holder from ALF 3 pages 43.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under Corporations Law Section 671B. It details the substantial shareholding of Australian Leaders Fund Limited in Mayne Pharma Group Limited, including voting power, relevant interests, and associates. This type of filing is a notification of a major shareholding change, specifically the initial substantial holder notice. It is not a financial report, earnings release, or management report. It fits the definition of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2012-08-28 English
Preliminary Final Report 16 pages 341.7KB
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary Final Report' for the year ended 30 June 2012, which is a regulatory filing format used in Australia for preliminary final reports. It contains detailed financial statements including consolidated statement of comprehensive income, financial position, and cash flows, as well as commentary on operating performance, review of operations, and other financial details. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and analysis for the full fiscal year indicates this is a comprehensive financial report for the year, consistent with an Interim / Quarterly Report (IR) or Annual Report (10-K). However, since it is a preliminary final report for the full year ended 30 June 2012, it aligns with an Annual Report equivalent filing. The Appendix 4E is a preliminary final report required by ASX Listing Rule 4.3A, which is a form of annual report announcement in Australia. Therefore, the best fitting category is Annual Report (10-K). FY 2012
2012-08-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.